These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 30173149
1. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes. Bechman K, Tweehuysen L, Garrood T, Scott DL, Cope AP, Galloway JB, Ma MHY. J Rheumatol; 2018 Nov; 45(11):1515-1521. PubMed ID: 30173149 [Abstract] [Full Text] [Related]
2. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank SE, Sasso EH, Chernoff D, Forslind K, Petersson IF, Geborek P, van Vollenhoven RF. Ann Rheum Dis; 2015 Jun; 74(6):1102-9. PubMed ID: 24812287 [Abstract] [Full Text] [Related]
3. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes. Ruyssen-Witrand A, Guernec G, Nigon D, Tobon G, Jamard B, Rat AC, Vittecoq O, Cantagrel A, Constantin A. Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151 [Abstract] [Full Text] [Related]
6. Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden. Wallman JK, Eriksson JK, Nilsson JÅ, Olofsson T, Kristensen LE, Neovius M, Geborek P. J Rheumatol; 2016 Jul; 43(7):1292-9. PubMed ID: 27252420 [Abstract] [Full Text] [Related]
9. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis. Nair SC, Bijlsma JW, van der Werf JH, van der Veen MJ, Linn-Rasker SP, Vreugdenhil S, Lafeber FP, Welsing PM. J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710 [Abstract] [Full Text] [Related]
10. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register. Twigg S, Hensor EMA, Emery P, Tennant A, Morgan AW, Yorkshire Early Arthritis Register Consortium. J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806 [Abstract] [Full Text] [Related]
12. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab. Nordal HH, Brun JG, Hordvik M, Eidsheim M, Jonsson R, Halse AK. Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827 [Abstract] [Full Text] [Related]
13. Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial. Bouman CA, van Herwaarden N, van den Hoogen FH, Fransen J, van Vollenhoven RF, Bijlsma JW, Maas AV, den Broeder AA. Ann Rheum Dis; 2017 Oct; 76(10):1716-1722. PubMed ID: 28606961 [Abstract] [Full Text] [Related]
14. Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritis. Nakajima A, Aoki Y, Terayama K, Sonobe M, Takahashi H, Saito M, Nakagawa K. Mod Rheumatol; 2017 Nov; 27(6):967-972. PubMed ID: 28271947 [Abstract] [Full Text] [Related]
15. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet. Bakker MF, Jacobs JW, Kruize AA, van der Veen MJ, van Booma-Frankfort C, Vreugdenhil SA, Bijlsma JW, Lafeber FP, Welsing PM. Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075 [Abstract] [Full Text] [Related]
16. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice. Katayama K, Okubo T, Sato T, Ito H, Fukai R, Baba H. Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407 [Abstract] [Full Text] [Related]
17. HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis. Lee KE, Choi SE, Xu H, Kang JH, Park DJ, Lee SS. Rheumatol Int; 2017 Dec; 37(12):2027-2034. PubMed ID: 28956118 [Abstract] [Full Text] [Related]
18. Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients. Lee HJ, Pok LSL, Ng CM, Yahya F, Sockalingam S, Tee YC, Raja J. Int J Rheum Dis; 2020 Aug; 23(8):1088-1093. PubMed ID: 32597545 [Abstract] [Full Text] [Related]
19. Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate. Smolen JS, van der Heijde DM, Keystone EC, van Vollenhoven RF, Goldring MB, Guérette B, Cifaldi MA, Chen N, Liu S, Landewé RB. Ann Rheum Dis; 2013 Jul; 72(7):1156-62. PubMed ID: 22915617 [Abstract] [Full Text] [Related]
20. A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study. Markusse IM, Dirven L, van den Broek M, Bijkerk C, Han KH, Ronday HK, Bolce R, Sasso EH, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF. J Rheumatol; 2014 Nov; 41(11):2114-9. PubMed ID: 25128518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]